R Grohmann

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. doi request reprint Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study
    R Grohmann
    Department of Psychiatry, School of Medicine, Ludwig Maximilians University, Nussbaumstraße 7, 80336, Munich, Germany
    Eur Arch Psychiatry Clin Neurosci 264:131-41. 2014
  2. pmc Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP
    Anne Haeberle
    Department of Psychiatry, Ludwig Maximilian University, Munich, Germany, Nussbaumstr, 7, Munich, 80336, Germany
    BMC Psychiatry 12:153. 2012
  3. ncbi request reprint Psychotropic drug use in psychiatric inpatients: recent trends and changes over time-data from the AMSP study
    R Grohmann
    Department of Psychiatry, Ludwig Maximilians University, Munich, Germany
    Pharmacopsychiatry 37:S27-38. 2004
  4. ncbi request reprint The AMUP study for drug surveillance in psychiatry - a summary of inpatient data
    R Grohmann
    Department of Psychiatry, Ludwig Maximilians University, Munich, Germany
    Pharmacopsychiatry 37:S16-26. 2004
  5. ncbi request reprint The AMSP drug safety program: methods and global results
    R Grohmann
    Department of Psychiatry, Ludwig Maximilians University of Munich, Munich, Germany
    Pharmacopsychiatry 37:S4-11. 2004
  6. ncbi request reprint Blood dyscrasias induced by psychotropic drugs
    S Stubner
    Department of Psychiatry, Ludwig Maximilians University, Munich, Germany
    Pharmacopsychiatry 37:S70-8. 2004
  7. ncbi request reprint Severe and uncommon involuntary movement disorders due to psychotropic drugs
    S Stubner
    Department of Psychiatry, Ludwig Maximilians University, Munich, Germany
    Pharmacopsychiatry 37:S54-64. 2004
  8. ncbi request reprint Research methods in drug surveillance
    R R Engel
    Department of Psychiatry, Ludwig Maximilians University, Munich, Germany
    Pharmacopsychiatry 37:S12-5. 2004
  9. ncbi request reprint [Considerations in the combination of clozapine and benzodiazepines]
    R Rupprecht
    Klinik für Psychiatrie und Psychotherapie der Ludwig Maximilians Universität München, Munchen, Deutschland
    Nervenarzt 75:857-60. 2004
  10. ncbi request reprint [Schizophrenic psychoses and suicide in the clinic. Risk factors, psychopharmacologic treatment]
    M Krupinski
    Psychiatrische Klinik der Ludwig Maximilians Universität München
    Nervenarzt 71:906-11. 2000

Collaborators

Detail Information

Publications22

  1. doi request reprint Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study
    R Grohmann
    Department of Psychiatry, School of Medicine, Ludwig Maximilians University, Nussbaumstraße 7, 80336, Munich, Germany
    Eur Arch Psychiatry Clin Neurosci 264:131-41. 2014
    ..Flupentixol has a stable place in the treatment of schizophrenia in spite of the introduction of different SGAs. Comparative ADR profiles suggest an intermediate position between FGAs and SGAs for flupentixol in clinical practice. ..
  2. pmc Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP
    Anne Haeberle
    Department of Psychiatry, Ludwig Maximilian University, Munich, Germany, Nussbaumstr, 7, Munich, 80336, Germany
    BMC Psychiatry 12:153. 2012
    ..It is largely unknown, to what extent the prescriptions in daily clinical routine correspond to these evidence based recommendations and which combinations of psychotropic drugs are frequently used...
  3. ncbi request reprint Psychotropic drug use in psychiatric inpatients: recent trends and changes over time-data from the AMSP study
    R Grohmann
    Department of Psychiatry, Ludwig Maximilians University, Munich, Germany
    Pharmacopsychiatry 37:S27-38. 2004
    ..TCAs and either SSRIs or other new ADs were still the most common AD combinations in 2001. Data were also analyzed according to the main diagnostic categories...
  4. ncbi request reprint The AMUP study for drug surveillance in psychiatry - a summary of inpatient data
    R Grohmann
    Department of Psychiatry, Ludwig Maximilians University, Munich, Germany
    Pharmacopsychiatry 37:S16-26. 2004
    ....
  5. ncbi request reprint The AMSP drug safety program: methods and global results
    R Grohmann
    Department of Psychiatry, Ludwig Maximilians University of Munich, Munich, Germany
    Pharmacopsychiatry 37:S4-11. 2004
    ..In addition, some overall data compiled on ADR rates from 1993 to 2000 are given...
  6. ncbi request reprint Blood dyscrasias induced by psychotropic drugs
    S Stubner
    Department of Psychiatry, Ludwig Maximilians University, Munich, Germany
    Pharmacopsychiatry 37:S70-8. 2004
    ..01 %). Although the methodological accuracy of these findings has to be critically discussed these data could be of considerable clinical relevance and should be helpful in making clinical treatment decisions...
  7. ncbi request reprint Severe and uncommon involuntary movement disorders due to psychotropic drugs
    S Stubner
    Department of Psychiatry, Ludwig Maximilians University, Munich, Germany
    Pharmacopsychiatry 37:S54-64. 2004
    ..81, df = 2, p < 0.0001). Our data provide important information on the frequency, severity, and the consequences of ARD for the patients' compliance, and thus are of clinical interest...
  8. ncbi request reprint Research methods in drug surveillance
    R R Engel
    Department of Psychiatry, Ludwig Maximilians University, Munich, Germany
    Pharmacopsychiatry 37:S12-5. 2004
    ..AMSP is compared to cohort studies and spontaneous reporting systems on the one hand, and the specialised PEM project, on the other. The possible influence of various sources of bias is critically analysed...
  9. ncbi request reprint [Considerations in the combination of clozapine and benzodiazepines]
    R Rupprecht
    Klinik für Psychiatrie und Psychotherapie der Ludwig Maximilians Universität München, Munchen, Deutschland
    Nervenarzt 75:857-60. 2004
    ..Moreover, the formulation of such guidelines would help with forensic issues in case of serious adverse events occurring during this combination therapy...
  10. ncbi request reprint [Schizophrenic psychoses and suicide in the clinic. Risk factors, psychopharmacologic treatment]
    M Krupinski
    Psychiatrische Klinik der Ludwig Maximilians Universität München
    Nervenarzt 71:906-11. 2000
    ....
  11. ncbi request reprint Disinhibition of libido: an adverse effect of SSRI?
    W Greil
    Department of Psychiatry, University of Munich, Nussbaumstr 7, D 80336 Munich, Germany
    J Affect Disord 62:225-8. 2001
    ....
  12. ncbi request reprint Asymptomatic bradycardia associated with amisulpride
    F Pedrosa Gil
    Department of Psychiatry, Z f P Weinsberg, Germany
    Pharmacopsychiatry 34:259-61. 2001
    ..The patient did not report any cardiovascular-related complaints. Since the cardiovascular-specific diagnostics did not yield any indicative results, bradycardia may be a rare complication of amisulpride treatment...
  13. ncbi request reprint Pharmacotherapy of personality disorders in German speaking countries: state and changes in the last decade
    M Heinze
    Department of Psychiatry and Psychotherapy, Klinikum Bremen Ost, Bremen, Germany
    Pharmacopsychiatry 38:201-5. 2005
    ..Empirically oriented studies of outcome and efficacy are still rare, and clinical practice is still dominated by a symptomatic and rather pragmatic approach...
  14. ncbi request reprint Galactorrhea due to psychotropic drugs
    S Kropp
    Department of Clinical Psychiatry and Psychotherapy, Medical School Hannover, Germany
    Pharmacopsychiatry 37:S84-8. 2004
    ..The AMSP data contribute to the knowledge on endocrine ADRs by the large number of patients examined and help clinicians select the appropriate drug if their patients have been prone to for these ADRs in the past...
  15. ncbi request reprint Hyperglycemia associated with antipsychotic treatment in a multicenter drug safety project
    S Kropp
    Department of Clinical Psychiatry and Psychotherapy, Hannover Medical School, Germany
    Pharmacopsychiatry 37:S79-83. 2004
    ..075 % for olanzapine. The symptomatology included reversible hyperglycemia, worsening of existing diabetes, and new-onset diabetes. Control for glycemic dysregulation should be maintained in clinical practice with these drugs...
  16. ncbi request reprint Cardiac adverse effects associated with psychotropic drugs
    C Schmid
    Psychiatric Hospital Merxhausen, Bad Emstal, Germany
    Pharmacopsychiatry 37:S65-9. 2004
    ..The results of the project can help clinicians select the appropriate drug for patients at risk to develop cardiac ADRs...
  17. ncbi request reprint Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics
    S Bender
    Department of Psychiatry and Psychotherapy, University of Duisburg Essen, Essen, Germany
    Pharmacopsychiatry 37:S46-53. 2004
    ....
  18. ncbi request reprint Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP
    D Degner
    Department of Psychiatry and Psychotherapy, Georg August University, Goettingen, Germany
    Pharmacopsychiatry 37:S39-45. 2004
    ..For drugs that potently inhibit serotonin uptake, serum sodium concentration should be controlled when applied in high-dose therapy or in vulnerable patients...
  19. ncbi request reprint Pseudohallucinations associated with moclobemide: a case report
    D Degner
    Department of Psychiatry and Psychotherapy, Georg August University of Gottingen, Germany
    Pharmacopsychiatry 38:179-81. 2005
    ..The symptoms occur 6 days after starting the medication and decline within two days after stopping moclobemide. The term "pseudohallucinations" is discussed controversially but still of high interest...
  20. ncbi request reprint Guillain-Barré syndrome after septicemia following clozapine-induced agranulocytosis. A case report
    J Mobascher
    Pharmacopsychiatry 38:329-30. 2005
    ..The case was recorded within the German surveillance project "drug safety in psychiatry" (AMSP)...
  21. ncbi request reprint Rivastigmin and impaired motor function
    M Heinze
    Department of Psychiatry and Psychotherapy, Landesklinik Teupitz, Teupitz, Germany
    Pharmacopsychiatry 35:79-80. 2002
    ..There have been reports on motor dysfunctions caused by other choline esterase inhibitors...
  22. ncbi request reprint Risk factors for suicides of inpatients with depressive psychoses
    M Krupinski
    Psychiatric Hospital, University of Munich, Germany
    Eur Arch Psychiatry Clin Neurosci 248:141-7. 1998
    ..Many of the risk factors discussed in the literature may be of little predictive value at least in the initial stages of hospital treatment...